leptacline

{{Chembox

| ImageFile = Leptacline.svg

| ImageSize = 200px

| ImageAlt =

| PIN = 1-(Cyclohexylmethyl)piperidine

| OtherNames = Piperidino-1-(methylcyclohexane)

|Section1={{Chembox Identifiers

| CASNo = 5005-72-1

| CASNo_Ref = {{cascite|correct|CAS}}

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = 5DXM29256P

| PubChem = 71660

| ChemSpiderID = 64719

| InChI = 1S/C12H23N/c1-3-7-12(8-4-1)11-13-9-5-2-6-10-13/h12H,1-11H2

| InChIKey = SFSYFLJDJQTPNM-UHFFFAOYSA-N

| SMILES = C1CCC(CC1)CN2CCCCC2}}

|Section2={{Chembox Properties

| C=12 | H=23 | N=1

| Appearance =

| Density =

| MeltingPt =

| BoilingPt =

| Solubility = }}

|Section3={{Chembox Hazards

| MainHazards =

| FlashPt =

| AutoignitionPt = }}

}}

Leptacline (INN; developmental code name SD 210-32) is a drug described as a respiratory stimulant that was never marketed.{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA331|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=331–}} It has a similar chemical structure to various piperidine and piperazine psychostimulants.